Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon May 08, 2021 11:38pm
89 Views
Post# 33161187

RE:Interesting ...

RE:Interesting ...
MrMugsy wrote: How fear really gets to some - wow !

They fear the company, the process, the direction, they even fear other investors - on a discussion board.  Love it !

When in fact, if you understood the CEO and his approach, you wouldn't really fear anything - you would build your plan in accordance with how it unfolds.

For example ...

You know Goodman is a very good businessman.
If you were to ask other CEOs who work with Goodman, you would see the respect held for the guy.  "A shrewed businessman who knows his stuff - but very fair."

If you look at the investor base - you know it is strong and unwavering.  That's exactly what this investment needs (as it's a long play) or it falls apart.  There isn't any room for wishy-washy changes in direction.  It's a full commitment to the process.

The base is only going to get stronger here and the mix of investors will slowly start to change.  As the efficiency improves, the business accumen becomes obvious.
As new drugs are added to the (now present) structure, the plan becomes obvious.
As new partnershps are added - the genius comes through.

"Pay me now" or "pay me later" rings loudly.  In this type of investment, "pay me later" doesn't work - like putting the cart before the horse.

You must pay the price in the early days (to buld the network) or you just can't build the drug platform in an efficient manner w.r.t. ROW.

It's much easier to add smaller geographies over time - now that the base is there.

We are just lucky that Goodman was able (with foresight) to accumulate enough cash in the early days - to be able to create the machine at the right time.

Very exciting ... but no one is promising that rose garden for tomorrrow.




One of the dumbest rants I've ever read on this forum. It is truly comical lolll...You've managed to out-do even yourself. Truly a retarded rant when you consider this CEO has underperformed the Canadian market by over 75 points, by far one of the worst performances in the entire country. Shareholders have been crushed by 40% in 6 years and this guy is praising the most underperforming CEO in Canada. Even the mainstream business media and long term 'believers' are asking questions. Put down the crack pipe and get a reality check. 

<< Previous
Bullboard Posts
Next >>